ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,551,496, issued on Feb. 17, was assigned to VDF FutureCeuticals Inc. (Momence, Ill.).

"Betalain compositions and methods therefor" was invented by Zbigniew Pietrzkowski (Momence, Ill.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Contemplated compositions and methods employ betalains for treatment of various conditions, and especially osteoarthritis, sinusitis, contact dermatitis, acne, an allergic condition, reduced mental alertness, reduced physical strength, reduced physical endurance, and/or impaired mood."

The patent was filed on Aug. 24, 2023, under Application No. 18/455,539.

*For further information, including images, charts and tables, pleas...